The Antioxidant and Antiatherogenic Effects of MAK-4 in WHHL Rabbits

Journal of Alternative and Complementary Medicine, Vol. 2, No. 4, pp. 463-478, 1996.

Jae Y. Lee, PhD, Atef N. Hanna, PhD, John A. Lott, PhD, and Hari M. Sharma, MD, FRCPC.

Conducted at
Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH 43210


This study tested the effect of MAK-4 on the development of atheroma in WHHL rabbits. Eleven rabbits were divided into two groups: controls (n = 5) and a group fed 6% (w/w) MAK-4 (n = 6). Blood was drawn for biochemical analysis every two months and at necropsy, six months after the special diet was started. The aortas were preserved in formalin. The percentage area of aortic arch covered with visible plaque in the MAK-4 group (22.5 ± 4.2%, mean ± SE) was significantly reduced (p <0.01) compared to the control group (47.6 ± 6.8%, mean ± SE). The MAK-4 group showed a significant decrease (p <0.05) in lipid peroxide, and a significant increase (p <0.05) in glutathione peroxidase and resistance of LDL to endothelial cell-induced and cupric ion-catalyzed oxidation (4.5 h and 5 h lag phase, respectively, for the MAK-4 group; 0 h lag phase for both for the controls). These findings suggest MAK-4 reduces atheroma formation through its antioxidant activity. See Cardiovascular Research for more information on this study.

Please Note

MAK-4 is now called Amrit Kalash Nectar.

The sole purpose of these articles is to provide information about the tradition of ayurveda. This information is not intended for use in the diagnosis, treatment, cure or prevention of any disease. If you have any serious acute or chronic health concern, please consult a trained health professional who can fully assess your needs and address them effectively. If you are seeking the medical advice of a trained ayurvedic expert, call or e-mail us for the number of a physician in your area. Check with your doctor before taking herbs or using essential oils when pregnant or nursing.